Diabetes and COVID-19 Pandemic: A Potential Mechanisms: A Review

Authors

  • Hind Shakir Ahmed1 , Hiba Shakir Ahmed2

DOI:

https://doi.org/10.37506/ijfmt.v15i1.13734

Keywords:

Diabetes mellitus, Coronavirus disease, Severe acute respiratory syndrome-coronavirus-2, Metformin, Dipeptidyl peptidase 4 inhibitors.

Abstract

Diabetes is the greatest public condition among patients with coronavirus disease and has been found to
affect prognosis worldwide. It is revealed that hyperglycemia is one of the elements that elevates the risk of
consequences in these persons. This study designed to analysis the overall features of the novel coronavirus
and provide an understanding of the coronavirus disease in diabetic patients, and its treatment.
These patients are usually treated with various medications and this review clarify the role of metformin
and dipeptidyl peptidase 4 inhibitors as helpful factors in these patients. Recommendations are made on
the probable pathophysiological mechanisms of the association between coronavirus and diabetes, and its
management. Additional study about this association and its clinical managing is necessary

Author Biography

Hind Shakir Ahmed1 , Hiba Shakir Ahmed2

1
Assistant Professor, Department of Chemistry, College of Education for Pure Science (Ibn Al-Haitham)/
University of Baghdad, Baghdad-Iraq, 2 Lecturer, Department of Microbiology, College of Science/ Al-Karkh
University for Science, Baghdad/Iraq

Published

2020-12-31

How to Cite

Hind Shakir Ahmed1 , Hiba Shakir Ahmed2. (2020). Diabetes and COVID-19 Pandemic: A Potential Mechanisms: A Review. Indian Journal of Forensic Medicine & Toxicology, 15(1), 2224-2231. https://doi.org/10.37506/ijfmt.v15i1.13734

Issue

Vol. 15 No. 1 (2021): Indian Journal of Forensic Medicine & Toxicology

Section

Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details

https://creativecommons.org/licenses/

CC BY

This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.

  1. The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
  1. The journal allows the author(s) to hold the copyright without restrictions.
  1. The journal allows the author(s) to retain publishing rights without restrictions